Healthcare

Clinuvel Pharmaceuticals Limited (ASX:CUV) recorded a marginal share price increase during the latest trading session, with shares trading at AUD 9.38, up 0.11% at the time of writing on 7 August 2026. The movement occurred during a session where the broader healthcare sector experienced …

The sale would convert Wellnex’s flagship asset into funds for debt repayment, working capital and future growth. It would also leave the company reliant on a smaller portfolio of retained consumer-healthcare products and contract manufacturing, making post-sale execution central to the investment case.

Botanix Pharmaceuticals Limited (ASX:BOT) drew fresh market attention after closing at AUD 0.023 on 6 August 2026, up 9.52% for the session. The rise refocused attention on the US launch of Sofdra for primary axillary hyperhidrosis and the company’s most recent operational or corporate …

The milestone expands access for a product developed to protect repaired peripheral nerves. Its commercial significance will now depend on product availability, surgeon adoption and the conversion of regulatory approval into sustained orders.

PainChek Limited (ASX:PCK) drew fresh market attention after closing at AUD 0.115, up 15.00% for the session. The rise refocused attention on its AI-assisted pain assessment and monitoring platform and the company’s most recent operational or corporate filing. With a market capitalisation of approximately …

TELIX Pharmaceuticals Ltd (ASX:TLX) closed at AUD 15.04 at the close of trading on 6 August 2026, up 2.17% for the session. The broader S&P/ASX 200 Health Care (ASX: XHJ) Index advanced +0.81% to close at 28,235.50 points, while the S&P/ASX 200 (ASX: XJO) …

PYC Therapeutics Ltd (ASX:PYC) closed at AUD 2.13 at the close of trading on 6 August 2026, up 1.43% for the session. The broader S&P/ASX 200 Health Care (ASX: XHJ) Index advanced +0.81% to close at 28,235.50 points, while the S&P/ASX 200 (ASX: XJO) …